Mr. Bruce Linton reports

CANOPY GROWTH COMPLETES GENETICS TRANSFER TO SPAIN AND PROVIDES UPDATE ON SPANISH OPERATIONS AND PARTNERSHIP

Canopy Growth Corp. has successfully completed a transfer of 1,500 cannabis clones to its Madrid-based partner, Alcaliber SA, completing the first phase of a partnership entered into by both parties as announced on Sept. 11, 2017.

Canopy Growth and Alcaliber enjoy a very strong and committed partnership which will continue to see Alcaliber producing cannabis genetics supplied by Canopy Growth subsidiaries for commercialization purposes.

Canopy Growth also wishes to clarify that, contrary to certain speculation, the company is not in negotiations to acquire Alcaliber.

"Our view of the European continent mirrors our Canadian expansion strategy," said Bruce Linton, chairman and chief executive officer, Canopy Growth. "We're diversifying our production capabilities on the continent in anticipation of rapid European market expansion. In addition to a large licensed production footprint in Odense, Denmark, we are working closely with our partner Alcaliber to capture market share by scaling supply."

The successful transfer marks the third continent with Canopy Growth genetics growing in soil today.

About Canopy Growth Corp.

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and softgel capsule forms.

Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates seven cannabis production sites with over one million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The company has operations in seven countries across four continents.

We seek Safe Harbor.